Clinical trial
Effects of Montelukast Therapy on Alzheimer's Disease (EMERALD)
NCT03991988 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Montelukast Therapy on Alzheimer's Disease (EMERALD)
- Lead sponsor
- Emory University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 25, 2019
- Completion date
- November 18, 2022
- Enrollment
- 32 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.